Chris Watters

Chris Watters serves as the Vice President and Franchise Head for the Neuroscience Business Unit at Ipsen since August 2019, where responsibilities include leading strategy and execution for the Neuroscience product portfolio in the US market. Previously, Chris held roles such as Head of Marketing for US Neuroscience and Senior Business Unit Head for Rare Disease and Neuroscience at Ipsen, along with positions like Vice President of Corporate Development at Cipher Pharmaceuticals Inc. and Senior Vice President of Global Marketing at goba Sports Group. Chris has also held leadership positions at GSK and Biovail, contributing to significant revenue growth and team development in various pharmaceutical sectors. Additionally, Chris is a member of the Board of Directors for CENE since June 2024, focusing on supporting Canadian entrepreneurs in technology and life sciences. Chris holds an Executive MBA from Northwestern University's Kellogg School of Management and a Bachelor of Pharmacy from the University of Toronto.